Adverse reactions to vaccines practice parameter 2012 update

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 1, 2012, Pages 25-43

  Kelso, John M ^a   Greenhawt, Matthew J ^a   Li, James T ^a   Nicklas, Richard A ^a   Bernstein, David I ^a   Blessing Moore, Joann ^a   Cox, Linda ^a   Khan, David ^a   Lang, David M ^a   Oppenheimer, John ^a   Portnoy, Jay M ^a   Randolph, Christopher R ^a   Schuller, Diane E ^a   Spector, Sheldon L ^a   Tilles, Stephen A ^a   Wallace, Dana ^a  

^a NONE

Author keywords

adverse reaction; allergy; egg allergy; immunization; influenza vaccine; Vaccine

Indexed keywords

ALLERGEN; ALUMINUM; CHICKENPOX MEASLES MUMPS RUBELLA VACCINE; CHICKENPOX VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA VACCINE; GELATIN; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; IMMUNOGLOBULIN G ANTIBODY; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LATEX; LIVE VACCINE; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MUMPS VACCINE; NEOMYCIN; OVALBUMIN; POLIOMYELITIS VACCINE; RABIES VACCINE; RECOMBINANT HEPATITIS B VACCINE; RUBELLA VACCINE; TETANUS TOXOID; THIOMERSAL; TYPHOID VACCINE; UNINDEXED DRUG; VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

ADVERSE DRUG REACTION; ALLERGIC REACTION; ANAPHYLAXIS; ARTICLE; ATOPY; AUTISM; CONTACT DERMATITIS; DRUG CONTRAINDICATION; DRUG INDICATION; EGG ALLERGY; EPIDEMIOLOGICAL DATA; FEVER; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; INJECTION SITE EDEMA; INJECTION SITE NODULE; INJECTION SITE PAIN; INJECTION SITE REACTION; MACULOPAPULAR RASH; MEDICINAL YEAST; MULTIPLE SCLEROSIS; PREGNANT WOMAN; PRIORITY JOURNAL; PRURITUS; SKIN TEST; VACCINATION;

ANIMALS; DRUG HYPERSENSITIVITY; HUMANS; VACCINATION; VACCINES;

EID: 84862886526     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.04.003     Document Type: Article

References (169)

1. Anonymous. Ten great public health achievements - United States, 1900-1999 MMWR Morb Mortal Wkly Rep 48 1999 241 243
2. S.W. Roush, and T.V. Murphy Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States JAMA 298 2007 2155 2163 (Pubitemid 350106654)
3. Centers for Disease Control and Prevention. Recommended immunization schedule for persons aged 0 through 6 years United States 2011. Available at: http://www.cdc.gov/vaccines/recs/schedules/downloads/child/0-6yrs-schedule-pr. pdf. Accessed April 24, 2012.
4. Centers for Disease Control and Prevention. Recommended immunization schedule for persons aged 7 through 18 years United States 2011. Available at: http://www.cdc.gov/vaccines/recs/schedules/downloads/child/7-18yrs-schedule-pr. pdf. Accessed April 24, 2012.
5. Centers for Disease Control and Prevention. Recommended adult immunization schedule United States 2011. Available at: http://www.cdc.gov/ vaccines/recs/schedules/downloads/adult/adult-schedule.pdf. Accessed April 24, 2012.
6. D.A. Salmon, M. Haber, E.J. Gangarosa, L. Phillips, N.J. Smith, and R.T. Chen Health consequences of religious and philosophical exemptions from immunization laws: individual and societal risk of measles JAMA 282 1999 47 53 (Pubitemid 29318932)
7. M.C. Danovaro-Holliday, C.W. LeBaron, C. Allensworth, R. Raymond, T.G. Borden, and A.B. Murray A large rubella outbreak with spread from the workplace to the community JAMA 284 2000 2733 2739
8. Anonymous. Update: outbreak of poliomyelitis - Dominican Republic and Haiti, 2000-2001 MMWR Morb Mortal Wkly Rep 50 2001 855 856
9. Anonymous. Two fatal cases of adenovirus-related illness in previously healthy young adults - Illinois, 2000 MMWR Morb Mortal Wkly Rep 50 2001 553 555
10. A.A. Parker, W. Staggs, G.H. Dayan, I.R. Ortega-Sanchez, P.A. Rota, and L. Lowe Implications of a 2005 measles outbreak in Indiana for sustained elimination of measles in the United States N Engl J Med 355 2006 447 455 (Pubitemid 44162272)
11. General recommendations on immunization - recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 60 2011 1 64
12. Vaccine excipient and media summary, by excipient W. Atkinson, S. Wolfe, and J. Hamborsky Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases 12th ed. 2011 Public Health Foundation Washington (DC)
13. R.L. Rietschel, and R. Bernier Neomycin sensitivity and the MMR vaccine JAMA 245 1981 571 (Pubitemid 11141828)
14. D. Elliman, and B. Dhanraj Safe MMR vaccination despite neomycin allergy Lancet 337 1991 365
15. N.H. Cox, and A. Forsyth Thiomersal allergy and vaccination reactions Contact Dermatitis 18 1988 229 233
16. R.L. Rietschel, and R.M. Adams Reactions to thimerosal in hepatitis B vaccines Dermatol Clin 8 1990 161 164 (Pubitemid 20097281)
17. I. Noel, A. Galloway, and F.A. Ive Hypersensitivity to thiomersal in hepatitis B vaccine Lancet 338 1991 705
18. W. Aberer Vaccination despite thimerosal sensitivity Contact Dermatitis 24 1991 6 10
19. M.T. Audicana, D. Munoz, M.D. del Pozo, E. Fernandez, G. Gastaminza, and L. Fernandez de Corres Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal Am J Contact Dermatitis 13 2002 3 9 (Pubitemid 34205622)
20. A. Patrizi, L. Rizzoli, C. Vincenzi, P. Trevisi, and A. Tosti Sensitization to thimerosal in atopic children Contact Dermatitis 40 1999 94 97 (Pubitemid 29054395)
21. M. Lee-Wong, D. Resnick, and K. Chong A generalized reaction to thimerosal from an influenza vaccine Ann Allergy Asthma Immunol 94 2005 90 94 (Pubitemid 40129642)
22. K. Kaaber, A.O. Nielsen, and N.K. Veien Vaccination granulomas and aluminium allergy: course and prognostic factors Contact Dermatitis 26 1992 304 306
23. E. Bergfors, B. Trollfors, and A. Inerot Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer Vaccine 22 2003 64 69 (Pubitemid 37357152)
24. H.K. Lehman, H.S. Faden, Y.V. Fang, and M. Ballow A case of recurrent sterile abscesses following vaccination: delayed hypersensitivity to aluminum J Pediatr 152 2008 133 135 (Pubitemid 350265940)
25. K. Bohlke, R.L. Davis, S.M. Marcy, M.M. Braun, F. DeStefano, and S.B. Black Risk of anaphylaxis after vaccination of children and adolescents Pediatrics 112 2003 815 820 (Pubitemid 37248689)
26. K.R. Stratton, C.J. Howe, and R.B. Johnston Adverse events associated with childhood vaccines: evidence bearing on causality 1994 National Academy Press Washington (DC)
27. R.T. Chen, S.C. Rastogi, J.R. Mullen, S.W. Hayes, S.L. Cochi, and J.A. Donlon The Vaccine Adverse Event Reporting System (VAERS) Vaccine 12 1994 542 550
28. Vaccine Adverse Event Reporting System (VAERS). Available at: vaers.hhs.gov. Accessed April 24, 2012.
29. S.A. Plotkin Immunologic correlates of protection induced by vaccination Pediatr Infect Dis J 20 2001 63 75 (Pubitemid 32066180)
30. A.E. Fiore, S.M. Feinstone, and B.P. Bell Hepatitis A vaccines S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
31. Centers for Disease Control and Prevention Epidemiology and prevention of vaccine-preventable diseases 11th ed. 2009 Public Health Foundation Washington (DC)
32. P.M. Strebel, M.J. Papania, G.H. Dayan, and N.A. Halsey Measles vaccine S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
33. S.A. Plotkin, and E. Vidor Poliovirus vaccine-inactivated S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
34. K.M. Edwards, and M.D. Decker Pertussis vaccines S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
35. S.A. Plotkin, and S.E. Reef Rubella vaccine S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
36. J.M. Kelso Adverse reactions to vaccines for infectious diseases N.F. Adkinson, B.S. Bochner, W.W. Busse, S.T. Holgate, R.F. Lemanske, F.E.R. Simons, Middleton's allergy: principles & practice 7th ed. 2008 Mosby Philadelphia 1189 1204
37. R.A. Wood, M. Berger, S.C. Dreskin, R. Setse, R.J.M. Engler, and C.L. Dekker An algorithm for treatment of patients with hypersensitivity reactions after vaccines Pediatrics 122 2008 e771 e777
38. J.M. Kelso, R.T. Jones, and J.W. Yunginger Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin J Allergy Clin Immunol 91 1993 867 872 (Pubitemid 23118503)
39. M. Sakaguchi, T. Nakayama, and S. Inouye Food allergy to gelatin in children with systemic immediate-type reactions, including anaphylaxis, to vaccines J Allergy Clin Immunol 98 1996 1058 1061 (Pubitemid 27014797)
40. M. Sakaguchi, T. Yamanaka, K. Ikeda, Y. Sano, H. Fujita, and T. Miura IgE-mediated systemic reactions to gelatin included in the varicella vaccine J Allergy Clin Immunol 99 1997 263 264 (Pubitemid 27091580)
41. M. Sakaguchi, H. Miyazawa, and S. Inouye Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines Allergy 56 2001 536 539 (Pubitemid 32521435)
42. T. Nakayama, and C. Aizawa Change in gelatin content of vaccines associated with reduction in reports of allergic reactions J Allergy Clin Immunol 106 2000 591 592 (Pubitemid 32037715)
43. O. Zent, and R. Hennig Post-marketing surveillance of immediate allergic reactions: polygeline-based versus polygeline-free pediatric TBE vaccine Vaccine 23 2004 579 584 (Pubitemid 39473186)
44. M. Fischer, N. Lindsey, J.E. Staples, and S. Hills Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 59 2010 1 27
45. J. Bogdanovic, N.A. Halsey, R.A. Wood, and R.G. Hamilton Bovine and porcine gelatin sensitivity in children sensitized to milk and meat J Allergy Clin Immunol 124 2009 1108 1110
46. T.C. O'Brien, C.J. Maloney, and N.M. Tauraso Quantitation of residual host protein in chicken embryo-derived vaccines by radial immunodiffusion Appl Microbiol 21 1971 780 782
47. M.B. Fasano, R.A. Wood, S.K. Cooke, and H.A. Sampson Egg hypersensitivity and adverse reactions to measles, mumps, and rubella vaccine J Pediatr 120 1992 878 881
48. J.M. James, A.W. Burks, P.K. Roberson, and H.A. Sampson Safe administration of the measles vaccine to children allergic to eggs N Engl J Med 332 1995 1262 1266
49. D.N. Baxter Measles immunization in children with a history of egg allergy Vaccine 14 1996 131 134 (Pubitemid 26074239)
50. Red Book - report of the Committee on Infectious Diseases 28th ed. 2009 American Academy of Pediatrics Elk Grove Village (IL)
51. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011 MMWR Morb Mortal Wkly Rep 60 2011 1128 1132
52. J.M. James, R.S. Zeiger, M.R. Lester, M.B. Fasano, J.E. Gern, and L.E. Mansfield Safe administration of influenza vaccine to patients with egg allergy J Pediatr 133 1998 624 628 (Pubitemid 28521210)
53. E.Y. Chung, L. Huang, and L. Schneider Safety of influenza vaccine administration in egg-allergic patients Pediatrics 125 2010 e1024 e1030
54. R. Gagnon, M.N. Primeau, A. Des Roches, C. Lemire, R. Kagan, and S. Carr Safe vaccination of patients with egg allergy with an adjuvanted pandemic H1N1 vaccine J Allergy Clin Immunol 126 2010 317 323
55. M.J. Greenhawt, A.S. Chernin, L. Howe, J.T. Li, and G. Sanders The safety of the H1N1 influenza A vaccine in egg allergic individuals Ann Allergy Asthma Immunol 105 2010 387 393
56. G. Owens, and A. Macginnitie Higher-ovalbumin-content influenza vaccines are well tolerated in children with egg allergy J Allergy Clin Immunol 127 2011 264 265
57. L.E. Howe, A.S. Conlon, M.J. Greenhawt, and G.M. Sanders Safe administration of seasonal influenza vaccine to children with egg allergy of all severities Ann Allergy Asthma Immunol 106 2011 446 447
58. L. Webb, M. Petersen, S. Boden, V. Labelle, J.A. Bird, and D. Howell Single-dose influenza vaccination of patients with egg allergy in a multicenter study J Allergy Clin Immunol 128 2011 218 219
59. Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2011-2012 policy statement Pediatrics 2011 e-pub September 2, 2011
60. K.H. Waibel, and R. Gomez Ovalbumin content in 2009 to 2010 seasonal and H1N1 monovalent influenza vaccines J Allergy Clin Immunol 125 2010 749 751 e1
61. J.T. Li, M.A. Rank, D.L. Squillace, and H. Kita Ovalbumin content of influenza vaccines J Allergy Clin Immunol 125 2010 1412 1413
62. K.K. McKinney, L. Webb, M. Petersen, M. Nelson, and S. Laubach Ovalbumin content of 2010-2011 influenza vaccines J Allergy Clin Immunol 127 2011 1629 1632
63. J.M. Kelso Raw egg allergy - a potential issue in vaccine allergy J Allergy Clin Immunol 106 2000 990
64. J.M. Kelso, G.E. Cockrell, R.M. Helm, and A.W. Burks Common allergens in avian meats J Allergy Clin Immunol 104 1999 202 204 (Pubitemid 29364505)
65. L. DiMiceli, V. Pool, J.M. Kelso, S.V. Shadomy, J. Iskander, and V.A.E.R.S. Team Vaccination of yeast sensitive individuals: review of safety data in the US vaccine adverse event reporting system (VAERS) Vaccine 24 2006 703 707 (Pubitemid 43190077)
66. J.T. Lear, and J.S. English Anaphylaxis after hepatitis B vaccination Lancet 345 1995 1249
67. M. Russell, V. Pool, J.M. Kelso, and V.J. Tomazic-Jezic Vaccination of persons allergic to latex: a review of safety data in the Vaccine Adverse Event Reporting System (VAERS) Vaccine 23 2004 664 667 (Pubitemid 39473196)
68. Latex in vaccine packaging W. Atkinson, S. Wolfe, and J. Hamborsky Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases 12th ed. 2011 Public Health Foundation Washington (DC)
69. P.L. Kwittken, S. Rosen, and S.K. Sweinberg MMR vaccine and neomycin allergy Am J Dis Child 147 1993 128 129
70. W. Zheng, and S.C. Dreskin Thimerosal in influenza vaccine: an immediate hypersensitivity reaction Ann Allergy Asthma Immunol 99 2007 574 575 (Pubitemid 350308761)
71. J.D. Kattan, G.N. Konstantinou, A.L. Cox, A. Nowak-Wegrzyn, G. Gimenez, and H.A. Sampson Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy J Allergy Clin Immunol 128 2011 215 218
72. J.E. Slater, R.L. Rabin, and D. Martin Comments on cow's milk allergy and diphtheria, tetanus, and pertussis vaccines J Allergy Clin Immunol 128 2011 434
73. Vaccine excipient and media summary, by vaccine W. Atkinson, S. Wolfe, and J. Hamborsky Centers for Disease Control and Prevention. Epidemiology and prevention of vaccine-preventable diseases 2011 Public Health Foundation Washington (DC)
74. R.A. Wood, R. Setse, and N. Halsey Irritant skin test reactions to common vaccines J Allergy Clin Immunol 120 2007 478 481 (Pubitemid 47102388)
75. J.E. Nagel, C. White, M.S. Lin, and P. Fireman IgE synthesis in man. II. Comparison of tetanus and diphtheria IgE antibody in allergic and nonallergic children J Allergy Clin Immunol 63 1979 308 314 (Pubitemid 10218811)
76. K. Edelman, K. Malmstrom, Q. He, J. Savolainen, E.O. Terho, and J. Mertsola Local reactions and IgE antibodies to pertussis toxin after acellular diphtheria-tetanus-pertussis immunization Eur J Pediatr 158 1999 989 994
77. R.C. Aalberse, R. van Ree, A. Danneman, and U. Wahn IgE antibodies to tetanus toxoid in relation to atopy Int Arch Allergy Immunol 107 1995 169 171
78. R. Anolik, W. Spiegel, M. Posner, and E. Jakabovics Influenza vaccine testing in egg sensitive patients Ann Allergy 68 1992 69
79. I.L. Bernstein, J.T. Li, D.I. Bernstein, R. Hamilton, S.L. Spector, and R. Tan Allergy diagnostic testing: an updated practice parameter Ann Allergy Asthma Immunol 100 suppl 2008 S1 S148
80. K.R. Murphy, and R.C. Strunk Safe administration of influenza vaccine in asthmatic children hypersensitive to egg proteins J Pediatr 106 1985 931 933 (Pubitemid 15006639)
81. YF-VAX [package insert] 2010 Sanofi Pasteur Lyon (France)
82. A.B. Carey, and E.O. Meltzer Diagnosis and "desensitization" in tetanus vaccine hypersensitivity Ann Allergy 69 1992 336 338
83. A.E. Fiore, T.M. Uyeki, K. Broder, L. Finelli, G.L. Euler, and J.A. Singleton Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 MMWR Morb Mortal Wkly Rep 59 2010 1 62
84. T. Lasky, G.J. Terracciano, L. Magder, C.L. Koski, M. Ballesteros, and D. Nash The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines N Engl J Med 339 1998 1797 1802 (Pubitemid 29005783)
85. V. Sivadon-Tardy, D. Orlikowski, R. Porcher, T. Sharshar, M.C. Durand, and V. Enouf Guillain-Barre syndrome and influenza virus infection Clin Infect Dis 48 2009 48 56
86. H.C. Lehmann, H.P. Hartung, B.C. Kieseier, and R.A. Hughes Guillain-Barre syndrome after exposure to influenza virus Lancet Infect Dis 10 2010 643 651
87. P. Haber, F. DeStefano, F.J. Angulo, J. Iskander, S.V. Shadomy, and E. Weintraub Guillain-Barre syndrome following influenza vaccination JAMA 292 2004 2478 2481 (Pubitemid 39552672)
88. N. Souayah, A. Nasar, M.F. Suri, and A.I. Qureshi Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System Vaccine 25 2007 5253 5255 (Pubitemid 46977531)
89. C. Vellozzi, K.R. Broder, P. Haber, A. Guh, M. Nguyen, and M. Cano Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010 Vaccine 28 2010 7248 7255
90. X.F. Liang, L. Li, D.W. Liu, K.L. Li, W.D. Wu, and B.P. Zhu Safety of influenza A (H1N1) vaccine in postmarketing surveillance in China N Engl J Med 364 2011 638 647
91. Centers for Disease Control and Prevention Update: vaccine side effects, adverse reactions, contraindications, and precautions. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 45 1996 1 35
92. W.E. Barlow, R.L. Davis, J.W. Glasser, P.H. Rhodes, R.S. Thompson, and J.P. Mullooly The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine N Engl J Med 345 2001 656 661
93. M. Vestergaard, A. Hviid, K.M. Madsen, J. Wohlfahrt, P. Thorsen, and D. Schendel MMR Vaccination and febrile seizures: evaluation of susceptible subgroups and long-term prognosis JAMA 292 2004 351 357 (Pubitemid 38944259)
94. M. Marin, K.R. Broder, J.L. Temte, D.E. Snider, and J.F. Seward Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 59 2010 1 12
95. J. Beeler, F. Varricchio, and R. Wise Thrombocytopenia after immunization with measles vaccines: review of the vaccine adverse events reporting system (1990 to 1994) Pediatr Infect Dis J 15 1996 88 90 (Pubitemid 26029252)
96. T. Jadavji, D. Scheifele, and S. Halperin Thrombocytopenia after immunization of Canadian children, 1992 to 2001 Pediatr Infect Dis J 22 2003 119 122 (Pubitemid 36228127)
97. C.P. Howson, and H.V. Fineberg Adverse events following pertussis and rubella vaccines. Summary of a report of the Institute of Medicine JAMA 267 1992 392 396
98. C.L. Cody, L.J. Baraff, J.D. Cherry, S.M. Marcy, and C.R. Manclark Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children Pediatrics 68 1981 650 660 (Pubitemid 11029708)
99. T.S. DuVernoy, and M.M. Braun Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996-1998 Pediatrics 106 2000 E52
100. H. Heijbel, M.C. Ciofi degli Atti, E. Harzer, J. Liese, M.P. Preziosi, and F. Rasmussen Hypotonic hyporesponsive episodes in eight pertussis vaccine studies Dev Biol Stand 89 1997 101 103
101. N. Le Saux, N.J. Barrowman, D.L. Moore, S. Whiting, D. Scheifele, and S. Halperin Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT Pediatrics 112 2003 e348
102. S. Rosenthal, R. Chen, and S. Hadler The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment Arch Pediatr Adolesc Med 150 1996 457 460 (Pubitemid 126515534)
103. A. Zielinski, and M. Rosinska Comparison of adverse effects following immunization with vaccine containing whole-cell vs. acellular pertussis components Przegl Epidemiol 62 2008 589 596
104. K.R. Broder, M.M. Cortese, J.K. Iskander, K. Kretsinger, B.A. Slade, and K.H. Brown Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mortal Wkly Rep 55 2006 1 34
105. S.G.F. Wassilak, M.H. Roper, K. Kretsinger, and W.A. Orenstein Tetanus toxoid S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
106. K. Kretsinger, K.R. Broder, M.M. Cortese, M.P. Joyce, I. Ortega-Sanchez, and G.M. Lee Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel MMWR Morb Mortal Wkly Rep 55 2006 1 37
107. E.A. Talbot, K.H. Brown, K.B. Kirkland, A.L. Baughman, S.A. Halperin, and K.R. Broder The safety of immunizing with tetanus-diphtheria-acellular pertussis vaccine (Tdap) less than 2 years following previous tetanus vaccination: experience during a mass vaccination campaign of healthcare personnel during a respiratory illness outbreak Vaccine 28 2010 8001 8007
108. J. Beytout, O. Launay, N. Guiso, A. Fiquet, M. Baudin, and P. Richard Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial Hum Vaccine 5 2009 315 321
109. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010 MMWR Morb Mortal Wkly Rep 60 2011 13 15
110. A.A. Gershon, M. Takahashi, and J.F. Seward Varicella vaccine S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
111. N. Goulleret, E. Mauvisseau, M. Essevaz-Roulet, M. Quinlivan, and J. Breuer Safety profile of live varicella virus vaccine (Oka/Merck): five-year results of the European Varicella Zoster Virus Identification Program (EU VZVIP) Vaccine 28 2010 5878 5882
112. R.P. Wise, M.E. Salive, M.M. Braun, G.T. Mootrey, J.F. Seward, and L.G. Rider Postlicensure safety surveillance for varicella vaccine JAMA 284 2000 1271 1279
113. R.G. Sharrar, P. LaRussa, S.A. Galea, S.P. Steinberg, A.R. Sweet, and R.M. Keatley The postmarketing safety profile of varicella vaccine Vaccine 19 2000 916 923
114. H.W. Kreth, P.H. Hoeger, and VZV-AD Study Group Safety, reactogenicity, and immunogenicity of live attenuated varicella vaccine in children between 1 and 9 years of age with atopic dermatitis Eur J Pediatr 165 2006 677 683 (Pubitemid 44310293)
115. L. Schneider, A. Weinberg, M. Boguniewicz, P. Taylor, H. Oettgen, and L. Heughan Immune response to varicella vaccine in children with atopic dermatitis compared with nonatopic controls J Allergy Clin Immunol 126 2010 1306 1307 e2
116. T.P. Monath, M.S. Cetron, and D.E. Teuwen Yellow fever vaccine S.A. Plotkin, W.A. Orenstein, P.A. Offit, Vaccines 2008 Elsevier Philadelphia
117. J.E. Staples, M. Gershman, and M. Fischer Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 59 2010 1 27
118. T.P. Monath, E. Fowler, C.T. Johnson, J. Balser, M.J. Morin, and M. Sisti An inactivated cell-culture vaccine against yellow fever N Engl J Med 364 2011 1326 1333
119. CDC Guidelines for vaccinating pregnant women from recommendations of the Advisory Committee on Immunization Practices (ACIP) 2007 Centers for Disease Control and Prevention Atlanta
120. W.J. Moss, C.J. Clements, and N.A. Halsey Immunization of children at risk of infection with human immunodeficiency virus Bull World Health Organ 81 2003 61 70 (Pubitemid 36168655)
121. L.M. Mofenson, M.T. Brady, S.P. Danner, K.L. Dominguez, R. Hazra, and E. Handelsman Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics MMWR Morb Mortal Wkly Rep 58 2009 1 166
122. S. Koppen, R. de Groot, H.J. Neijens, N. Nagelkerke, W. van Eden, and H.C. Rumke No epidemiological evidence for infant vaccinations to cause allergic disease Vaccine 22 2004 3375 3385 (Pubitemid 39078755)
123. M.C. Matheson, E. Haydn Walters, J.A. Burgess, M.A. Jenkins, G.G. Giles, and J.L. Hopper Childhood immunization and atopic disease into middle-age - a prospective cohort study Pediatr Allergy Immunol 21 2010 301 306
124. K. Stratton, A. Gable, and P. Shetty Immunization safety review: measles-mumps-rubella vaccine and autism 2001 National Academy Press Washington (DC)
125. K.M. Madsen, A. Hviid, M. Vestergaard, D. Schendel, J. Wohlfahrt, and P. Thorsen A population-based study of measles, mumps, and rubella vaccination and autism N Engl J Med 347 2002 1477 1482 (Pubitemid 35257586)
126. C. Confavreux, S. Suissa, P. Saddier, V. Bourdes, S. Vukusic, and Vaccines in Multiple Sclerosis Study Group Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group N Engl J Med 344 2001 319 326 (Pubitemid 32107639)
127. F. DeStefano, T. Verstraeten, L.A. Jackson, C.A. Okoro, P. Benson, and S.B. Black Vaccinations and risk of central nervous system demyelinating diseases in adults Arch Neurol 60 2003 504 509 (Pubitemid 36427964)
128. Food and Drug Administration. Thimerosal in vaccines. Available at: http://www.fda.gov/BiologicsBloodVaccines/SafetyAvailability/VaccineSafety/ UCM096228. Accessed April 24, 2012.
129. S.K. Parker, B. Schwartz, J. Todd, and L.K. Pickering Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data Pediatrics 114 2004 793 804 (Pubitemid 41529541)
130. W.W. Thompson, C. Price, B. Goodson, D.K. Shay, P. Benson, and V.L. Hinrichsen Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years N Engl J Med 357 2007 1281 1292 (Pubitemid 47481450)
131. M.J. Greenhawt, J.T. Li, D.I. Bernstein, J. Blessing-Moore, L. Cox, and D. Khan Administering influenza vaccine to egg allergic recipients: a focused practice parameter update Ann Allergy Asthma Immunol 106 2011 11 16
132. Recommendations for prevention and control of influenza in children, 2011-2012 Pediatrics 128 2011 813 825
133. W.W. Thompson, D.K. Shay, E. Weintraub, L. Brammer, C.B. Bridges, and N.J. Cox Influenza-associated hospitalizations in the United States JAMA 292 2004 1333 1340 (Pubitemid 39223224)
134. Estimates of deaths associated with seasonal influenza - United States, 1976-2007 MMWR Morb Mortal Wkly Rep 59 2010 1057 1062
135. A.E. Fiore, T.M. Uyeki, K. Broder, L. Finelli, G.L. Euler, and J.A. Singleton Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 MMWR Recomm Rep 59 2010 1 62
136. J.A. Boyce, A. Assa'ad, A.W. Burks, S.M. Jones, H.A. Sampson, and R.A. Wood Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel J Allergy Clin Immunol 126 suppl 2010 S1 S58
137. L. Cox, H. Nelson, R. Lockey, C. Calabria, T. Chacko, and I. Finegold Allergen immunotherapy: a practice parameter third update J Allergy Clin Immunol 127 suppl 2011 S1 S55
138. Practice parameters for the diagnosis and treatment of asthma J Allergy Clin Immunol 96 suppl 1995 S707 S870
139. Practice parameters for allergy diagnostic testing Ann Allergy 75 1995 543 625
140. Practice parameters for the diagnosis and management of immunodefciency Ann Allergy 76 1996 282 294
141. Practice parameters for allergen immunotherapy J Allergy Clin Immunol 98 1996 1001 1011
142. Disease management of atopic dermatitis: a practice parameter Ann Allergy 79 1997 197 211
143. The diagnosis and management of anaphylaxis J Allergy Clin Immunol 101 suppl 1998 S465 S528
144. Algorithm for the diagnosis and management of asthma: a practice parameter update Ann Allergy 81 1998 415 420
145. Diagnosis and management of rhinitis: parameter documents of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology Ann Allergy 81 suppl 1998 S463 S518
146. Parameters for the diagnosis and management of sinusitis J Allergy Clin Immunol 102 suppl 1998 S107 S144
147. Stinging insect hypersensitivity: a practice parameter J Allergy Clin Immunol 103 1999 963 980
148. Disease management of drug hypersensitivity: a practice parameter Ann Allergy 83 suppl 1999 S665 S700
149. Diagnosis and management of urticaria: a practice parameter Ann Allergy 85 suppl 2000 S521 S544
150. Allergen immunotherapy: a practice parameter Ann Allergy 90 suppl 2003 SI-S540
151. Symptom severity assessment of allergic rhinitis Part I. Ann Allergy 91 2003 105 114
152. Disease management of atopic dermatitis: an updated practice parameter Ann Allergy 93 suppl 2004 S1 S21
153. Stinging insect hypersensitivity: a practice parameter update J Allergy Clin Immunol 114 2004 869 886
154. The diagnosis and management of anaphylaxis: an updated practice parameter J Allergy Clin Immunol 115 suppl 2005 S483 S523
155. Practice parameter for the diagnosis and management of primary immunodeficiency Ann Allergy 94 suppl 2005 S1 S63
156. Attaining optimal asthma control: a practice parameter J Allergy Clin Immunol 116 suppl 2005 S3 S11
157. The diagnosis and management of sinusitis: a practice parameter update J Allergy Clin Immunol 116 suppl 2005 S13 S47
158. Food allergy: a practice parameter Ann Allergy 96 suppl 2006 S1 S68
159. Contact dermatitis: a practice parameter Ann Allergy 97 suppl 2006 S1 S38
160. Allergen immunotherapy: a practice parameter second update J Allergy Clin Immunol 120 suppl 2007 S25 S85
161. I.L. Bernstein, J.T. Li, D.I. Bernstein, R. Hamilton, S. Spector, and R. Tan Allergy diagnostic testing: an updated practice parameter Ann Allergy 100 suppl 2008 S1 S147
162. D. Wallace, M. Dykewicz, D.I. Bernstein, J. Blessing-Moore, L. Cox, and D.A. Khan The diagnosis and management of rhinitis: an updated practice parameter J Allergy Clin Immunol 121 suppl 2008 S1 S84
163. J. Kelso, J.T. Li, R.A. Nicklas, J. Blessing-Moore, L. Cox, and D.M. Lng Adverse reactions to vaccines Ann Allergy 103 suppl 2009 S1 S14
164. P. Lieberman, R.A. Nicklas, J. Oppenheimer, S.F. Kemp, D.M. Lang, and D.I. Bernstein The diagnosis and management of anaphylaxis practice parameter: 2010 update J Allergy Clin Immunol 126 suppl 2010 477 480 e1-42
165. R. Solensky, D.A. Khan, I.L. Bernstein, G.L. Bloomberg, M.C. Castells, and L.M. Mendelson Drug allergy: an updated parameter Ann Allergy Asthma Immunol 105 2010 259 273
166. J.M. Weiler, S.A. Anderson, C. Randolph, S. Bonini, T.J. Craig, and D.S. Pearlman Pathogenesis, prevalence, diagnosis and management of exercise-induced bronchoconstriction: a practice parameter Ann Allergy 105 suppl 2010 S1 S47
167. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 127(suppl):S1-55.
168. M.J. Greenhawt, and J.T. Li Administering influenza vaccine to egg allergic recipients: a focused practice parameter update Ann Allergy 106 2011 11 16
169. D.B. Golden, J. Moffitt, R.A. Nicklas, T. Freeman, D.F. Graft, and R.E. Reisman Stinging insect hypersensitivity: a practice parameter update 2011 J Allergy Clin Immunol 127 2011 852 854 e23